Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
In the European Union and the United Kingdom, setmelanotide is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed BBS or loss-of-function biallelic POMC, including PCSK1, deficiency or biallelic LEPR deficiency in adults and children 2 years of age and above
The peak level of GH was observed between 60 and 120 min after injection, peaking most frequently at 90 min post-injection
Weight Loss Results Studies suggest that people can lose somewhere between 5% -20% of their body weight These losses are typically sustained while taking the medication Some studies have suggested that these medication are more effective than other traditional weight loss methods 2
Ci thin n hi v chng lo ha: Ngn nga np nhn, gip da cng bng v mn mng hn
US$ 21.85
US$ 27.13
US$ 25.19
US$ 27.32
US$ 29.23
US$ 27.45
US$ 22.72
